Use of a Medical Food in Adults Undergoing Surgery

Stopped early · Not applicable

Conditions studied: Compliance, Patient

In brief

Multi-center, prospective, one arm study to evaluate the addition of a medical food to the standard of care in elderly adults undergoing a surgical procedure.

Key facts

Study ID

NCT04041908

Run by

Abbott Nutrition

People needed

1

Starts

2020-03-13

Expected to finish

2020-04-10

Last updated by the study team

2020-05-01

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant is scheduled to have non-melanoma skin cancer on either the head, leg, trunk and arm removed with final wound size of 1.0 to < 5.0 cm in diameter or with 1.0 < 5.0 cm long axis if not circular that will be healed by secondary intent
• Participant has an acceptable state of health and nutrition
• Participant agrees not to begin taking any new medications, dietary supplements, or alternative therapies during the study period
• Participant is interested in participating in the study, willing to comply with the study protocol, and willing to consume two servings of drink mix per day according to the protocol
• Participant has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability (HIPAA) authorization prior to any study participation

You may not qualify if…

• Participant has a disease or condition that could interfere with the assessment of safety and efficacy of the study treatment and compliance of the participant with study visits/procedures
• Participant has type 1 diabetes mellitus or uncontrolled type 2 diabetes mellitus
• Participant has known immunosuppression
• Participant has platelet or coagulation disorders
• Therapy with another investigational agent within 30 days of Visit 1 that has not been approved
• Systemic infection at the time of enrollment in the study
• Currently receiving or have received recombinant human platelet-derived growth factor or similar therapies, or other bioengineered tissue therapy within the previous 4 weeks
• Participant has an allergy or intolerance to any ingredient in the study product
• Participant is taking nutritional supplement(s)/capsules/formulas for wound healing and is unwilling to discontinue therapy for the duration of the study
• Participation in another clinical study

Where it is running

• ClinOhio Research Services — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.